Titan Pharmaceuticals
TTNP
#10383
Rank
A$8.65 M
Marketcap
A$6.51
Share price
-3.76%
Change (1 day)
4.27%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -A$4.33 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$6.65 Million, an increase over its 2023 earnings that were of -A$7.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.33 Million-34.93%
2024 -A$6.65 Million-15.5%
2023 -A$7.87 Million-45.43%
2022 -A$14.41 Million16.29%
2021 -A$12.39 Million-907.36%
2020 A$1.53 M-106.6%
2019 -A$23.24 Million82.4%
2018 -A$12.74 Million-36.93%
2017 -A$20.2 Million-378.62%
2016 A$7.24 M-145.53%
2015 -A$15.93 Million369.37%
2014 -A$3.4 Million-125.9%
2013 A$13.09 M-177.74%
2012 -A$16.85 Million13.59%
2011 -A$14.84 Million74.37%
2010 -A$8.51 Million3.61%
2009 -A$8.21 Million
2007 -A$26.03 Million12.08%
2006 -A$23.22 Million-28.65%
2005 -A$32.54 Million-10.03%
2004 -A$36.17 Million-6.08%
2003 -A$38.51 Million-14.76%
2002 -A$45.18 Million32.52%
2001 -A$34.1 Million27.55%
2000 -A$26.73 Million62.5%
1999 -A$16.45 Million4.04%
1998 -A$15.82 Million49.33%
1997 -A$10.59 Million-27.88%
1996 -A$14.69 Million13.04%
1995 -A$12.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.73 B-1,155,037.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$23.08 B-583,059.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-A$0.18 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$36.9 M-1,031.98%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$16.95 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.37 Billion 9,035.12%๐Ÿ‡บ๐Ÿ‡ธ USA